Marathon Trading Investment Management LLC Inmune Bio, Inc. Transaction History

Marathon Trading Investment Management LLC

$589 Million
Q4 2024

1 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2024 May 10, 2024	BUY	$10.53 - $14.01 $152,685 - $203,145	14,500 New	14,500 $170,000

Others Institutions Holding INMB

# of Institutions

Shares Held

7.04M

Call Options Held

202K

Put Options Held

42.9K

Black Rock Inc. New York, NY

813K
Shares

$6.06 Million
0.0% of portfolio
Praetorian Pr LLC Rincon, PR

812K
Shares

$6.06 Million
1.52% of portfolio
Vanguard Group Inc Valley Forge, PA

738K
Shares

$5.51 Million
0.0% of portfolio
Cvi Holdings, LLC Wilmington, DE

596K
Shares

$4.45 Million
45.87% of portfolio
Raymond James Financial Inc St. Petersburg, FL

476K
Shares

$3.55 Million
0.0% of portfolio

View Full List

About Inmune Bio, Inc.

Ticker INMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,946,000
Market Cap $134M
Description
INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...

More about INMB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marathon Trading Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Marathon Trading Investment Management LLC with notifications on news.

Account